Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma [16]

Leukemia

Volumn 21, Issue 4, 2007, Pages 838-842

  Bonvini, P ^a   Zorzi, E ^a   Basso, G ^a   Rosolen, A ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; BETA CATENIN; BH3 PROTEIN; BORTEZOMIB; CASPASE 3; CASPASE 8; CASPASE 9; CD30 ANTIGEN; CYCLIN A; CYCLIN B1; CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYTOCHROME C; DNA 26S; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN MCL 1; PROTEIN P53; STAT3 PROTEIN; SURVIVIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; HUMAN; LARGE CELL LYMPHOMA; LETTER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RECEPTOR UPREGULATION; SILENCER ELEMENT; SILENCER GENE;

EID: 33947356281     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404528     Document Type: Letter

References (8)

1. Adams J. The proteasome: A suitable antineoplastic target. Nat Rev Cancer 2004; 4: 349-360.
2. Boccadoro M, Morgan G, Cavenagh J. Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy. Cancer Cell Int 2005; 5: 1-9.
3. Pulford K, Morris SW, Turturro F. Anaplastic lymphoma kinase proteins in growth control and cancer. J Cell Physiol 2004; 199: 330-358.
4. Zheng B, Georgakis GV, Li Y, Bharti A, McConkey D, Aggarwal B B et al. Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors. Clin Cancer Res 2004; 10: 3207-3215.
5. Gu T-L, Tothova Z, Scheijen B, Griffin JD, Gilliland DG, Sternberg DW. NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a. Blood 2004; 103: 4622-4629.
6. Ricci JE, Gottlieb RA, Green DR. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J Cell Biol 2003; 160: 65-75.
7. Rust R, Harms G, Blokzijl T, Boot M, Diepstra A, Kluiver J et al. High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma. J Clin Pathol 2005; 58: 520-524.
8. Nencioni A, Hua F, Dillon CP, Yokoo R, Scheiermann C, Cardone MH et al. Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Blood 2005; 105: 3255-3262.